In this issue:
EULAR 2023 recommendations for SLE Treatment
Targeted-release budesonide modifies pathogenic biomarkers in IgA nephropathy
A phase 2 trial of sibeprenlimab in patients with IgA nephropathy
Experiences of Indigenous patients receiving dialysis
Adherence to plant-based diets and risk of CKD progression and all-cause mortality
Urine output following kidney transplantation and short-term and long-term outcomes
Adding salt to food and the risk of CKD
Vafseo approved for anaemia with CKD patients on maintenance dialysis
Prolia (denosumab): Boxed Warning of severe hypocalcaemia in advanced CKD
Pleiotropic benefits of vitamin D in diabetic kidney disease?
Novel mutations causing tubulointerstitial kidney disease with medullary amyloidosis
Dietary protein restriction in patients with CKD
CKD, diabetes, and hypertension associated with structural racism indicators
Please login below to download this issue (PDF)